King Pharmaceuticals Inc Stock Today
| KG Stock | 25.02 0.41 1.67% |
PerformanceGood
| Odds Of DistressLow
|
KING PHARMACEUTICALS is trading at 25.02 as of the 24th of June 2025. This is a 1.67 percent increase since the beginning of the trading day. The stock's lowest day price was 25.02. KING PHARMACEUTICALS has only a 6 % chance of going through financial distress over the next few years and had a good performance during the last 90 days. KING PHARMACEUTICALS symbol was changed from MHLD on 28th of May 2025. The performance scores are derived for the period starting the 26th of March 2025 and ending today, the 24th of June 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of June 1998 | Category Financial Services | Classification Health Care |
KING PHARMACEUTICALS is entity of United States. It is traded as Stock on NYSE exchange. The company has 9.94 M outstanding shares of which 65.4 K shares are now sold short in the market by investors with about 1.63 days to cover all shorted shares. More on KING PHARMACEUTICALS INC
Moving against KING Stock
KING Stock Highlights
| Older Symbol | MHLD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CEO Director | Bradford Ledbetter | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Insurance (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Financial Services, Insurance, Health Care, Pharmaceuticals, Pharmaceutical Products, Health Care (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
KING PHARMACEUTICALS can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand KING PHARMACEUTICALS's financial leverage. It provides some insight into what part of KING PHARMACEUTICALS's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
KING PHARMACEUTICALS INC (KG) is traded on New York Stock Exchange in USA and employs 4 people. KING PHARMACEUTICALS INC was previously known as Maiden Holdings and was traded on NASDAQ Exchange under the symbol MHLD. KING PHARMACEUTICALS is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a market capitalization of 244.61 M. KING PHARMACEUTICALS INC is active under Pharmaceuticals sector as part of Health Care industry. The entity has 9.94 M outstanding shares of which 65.4 K shares are now sold short in the market by investors with about 1.63 days to cover all shorted shares.
KING PHARMACEUTICALS INC reports about 545.31 M in cash with (1.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58.
Check KING PHARMACEUTICALS Probability Of Bankruptcy
Ownership AllocationThe majority of KING PHARMACEUTICALS outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in KING PHARMACEUTICALS INC to benefit from reduced commissions. Therefore, institutional holders are subject to a different set of regulations than regular investors in KING PHARMACEUTICALS INC. Please pay attention to any change in the institutional holdings of KING PHARMACEUTICALS as this could imply that something significant has changed or is about to change at the company.
Check KING Ownership Details
KING PHARMACEUTICALS Historical Income Statement
KING Stock Against Markets
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in KING PHARMACEUTICALS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of KING PHARMACEUTICALS. If investors know KING will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about KING PHARMACEUTICALS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.03 |
The market value of KING PHARMACEUTICALS INC is measured differently than its book value, which is the value of KING that is recorded on the company's balance sheet. Investors also form their own opinion of KING PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is KING PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because KING PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect KING PHARMACEUTICALS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between KING PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine if KING PHARMACEUTICALS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, KING PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.